Logo image of ALERS.PA

EUROBIO-SCIENTIFIC (ALERS.PA) Stock Price, Quote, News and Overview

EPA:ALERS - Euronext Paris - Matif - FR0013240934 - Common Stock - Currency: EUR

25.5  0 (0%)

ALERS.PA Quote, Performance and Key Statistics

EUROBIO-SCIENTIFIC

EPA:ALERS (6/18/2025, 7:00:00 PM)

25.5

0 (0%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High26.5
52 Week Low13.8
Market Cap261.38M
Shares10.25M
Float0
Yearly DividendN/A
Dividend YieldN/A
PE63.75
Fwd PE21.34
Earnings (Next)07-29 2025-07-29
IPO11-18 2005-11-18


ALERS.PA short term performance overview.The bars show the price performance of ALERS.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0.5 1 1.5

ALERS.PA long term performance overview.The bars show the price performance of ALERS.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80

The current stock price of ALERS.PA is 25.5 EUR. In the past month the price increased by 0.79%. In the past year, price increased by 81.37%.

EUROBIO-SCIENTIFIC / ALERS Daily stock chart

ALERS.PA Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
1ABBV.MI ABBVIE INC 18.61 293.65B
4AB.DE ABBVIE INC 17.98 283.33B
AMG.DE AMGEN INC 13.98 135.61B
GIS.DE GILEAD SCIENCES INC 14.1 118.04B
VX1.DE VERTEX PHARMACEUTICALS INC N/A 99.95B
1REGN.MI REGENERON PHARMACEUTICALS 11.92 49.56B
ARGX.BR ARGENX SE 101.25 28.75B
22UA.DE BIONTECH SE-ADR N/A 21.80B
IDP.DE BIOGEN INC 8.05 16.21B
1EXEL.MI EXELIXIS INC 18.83 9.81B
1MRNA.MI MODERNA INC N/A 8.71B
0QF.DE MODERNA INC N/A 8.47B

About ALERS.PA

Company Profile

ALERS logo image Eurobio-Scientific SA provides in vitro diagnostics solutions. The company is headquartered in Les Ulis, Ile-De-France and currently employs 329 full-time employees. The company went IPO on 2005-11-18. The company is engaged in activities ranging from discovery to the commercialization of specialty diagnostic products. The firm owns a portfolio of diagnostic products in three specialty areas: infectious diseases; Alzheimer's disease, and cancer. The company consists of Tetanos Quick Stick (TQS), which is an unitary test enabling to determine the tetanus vaccination status. The company has a portfolio of in-house and co-developed products, including AclarusDx (a blood-based test for the detection of biomarkers specific for Alzheimer's disease). The portfolio includes BJI Inoplex for prosthetic infections and EHT Dx14 for breast cancer (both in validation phase). The co-developed products include research programs for the identification of predictive biomarkers of response for anti-HER2 and anti-angiogenic therapies, among others. The company operates through Genbio and Eurobio Capforce Plus.

Company Info

EUROBIO-SCIENTIFIC

ZA de Courtaboeuf 7 Avenue de Scandinavie, Les Ulis Cedex

Les Ulis ILE-DE-FRANCE FR

Employees: 329

ALERS Company Website

ALERS Investor Relations

Phone: 331169796480

EUROBIO-SCIENTIFIC / ALERS.PA FAQ

What is the stock price of EUROBIO-SCIENTIFIC today?

The current stock price of ALERS.PA is 25.5 EUR.


What is the ticker symbol for EUROBIO-SCIENTIFIC stock?

The exchange symbol of EUROBIO-SCIENTIFIC is ALERS and it is listed on the Euronext Paris - Matif exchange.


On which exchange is ALERS.PA stock listed?

ALERS.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for EUROBIO-SCIENTIFIC stock?

9 analysts have analysed ALERS.PA and the average price target is 30.6 EUR. This implies a price increase of 20% is expected in the next year compared to the current price of 25.5. Check the EUROBIO-SCIENTIFIC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is EUROBIO-SCIENTIFIC worth?

EUROBIO-SCIENTIFIC (ALERS.PA) has a market capitalization of 261.38M EUR. This makes ALERS.PA a Micro Cap stock.


How many employees does EUROBIO-SCIENTIFIC have?

EUROBIO-SCIENTIFIC (ALERS.PA) currently has 329 employees.


What are the support and resistance levels for EUROBIO-SCIENTIFIC (ALERS.PA) stock?

EUROBIO-SCIENTIFIC (ALERS.PA) has a support level at 25.38 and a resistance level at 25.5. Check the full technical report for a detailed analysis of ALERS.PA support and resistance levels.


Is EUROBIO-SCIENTIFIC (ALERS.PA) expected to grow?

The Revenue of EUROBIO-SCIENTIFIC (ALERS.PA) is expected to grow by 9.49% in the next year. Check the estimates tab for more information on the ALERS.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy EUROBIO-SCIENTIFIC (ALERS.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does EUROBIO-SCIENTIFIC (ALERS.PA) stock pay dividends?

ALERS.PA does not pay a dividend.


When does EUROBIO-SCIENTIFIC (ALERS.PA) report earnings?

EUROBIO-SCIENTIFIC (ALERS.PA) will report earnings on 2025-07-29.


What is the Price/Earnings (PE) ratio of EUROBIO-SCIENTIFIC (ALERS.PA)?

The PE ratio for EUROBIO-SCIENTIFIC (ALERS.PA) is 63.75. This is based on the reported non-GAAP earnings per share of 0.4 and the current share price of 25.5 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ALERS.PA.


ALERS.PA Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to ALERS.PA. When comparing the yearly performance of all stocks, ALERS.PA is one of the better performing stocks in the market, outperforming 96.56% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ALERS.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to ALERS.PA. ALERS.PA scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALERS.PA Financial Highlights

Over the last trailing twelve months ALERS.PA reported a non-GAAP Earnings per Share(EPS) of 0.4. The EPS decreased by -7.6% compared to the year before.


Industry RankSector Rank
PM (TTM) 2.59%
ROA 1.55%
ROE 2.24%
Debt/Equity 0.17
Chartmill High Growth Momentum
EPS Q2Q%-100.04%
Sales Q2Q%14.74%
EPS 1Y (TTM)-7.6%
Revenue 1Y (TTM)18.89%

ALERS.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to ALERS.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 31.82% and a revenue growth 9.49% for ALERS.PA


Ownership
Inst Owners4.28%
Ins Owners0.16%
Short Float %N/A
Short RatioN/A
Analysts
Analysts84.44
Price Target30.6 (20%)
EPS Next Y31.82%
Revenue Next Year9.49%